Cytinnov Biotechnologies Ltd.

In Cytinnov Biotechnologies, we provide a cell-manufacturing process optimization service on a contract basis to biotechnology companies in the regenerative medicine field, in order to lower the cost of goods of their novel cell-based therapies. Cell-based therapies are poised to revolutionize healthcare, in Alberta and around the world. Promising to cure chronic diseases, and fully repair damaged tissues and organs, demand for these treatments will be tremendous – as will the costs. While the first few cell-based treatments have entered the Canadian health care market, the massive price tag serves as a bottleneck for the uptake of treatments by doctors, patents and the government. In some cases, the cost of goods alone for cell manufacturing is estimated to be in the tens and even hundreds of thousands of dollars per dose per patient. Effective, curative treatments may not see the light of day if they are not economically viable. The cost of cell manufacturing must come down to make cell therapies accessible. In Cytinnov Biotechnologies, we fill this need by providing cell manufacturing process optimization services on a contract basis. Over the past several years, we have engineered a biomedical platform integrating scalable cell culture, advanced statistical methods, Machine Learning, and robotic systems to systematically optimize cell manufacturing processes, making them cheaper, faster, and more robust. To our knowledge, we are the first company in the world to offer this service. A team of innovators, scientists and entrepreneurs, we are excited to take on the first mover advantage, and are providing optimization services to our first customer this fall. Let's make cell therapies accessible and revolutionize the future of healthcare!
Social Link - Linkedin: http://www. linkedin.com/company /cytinnov-biotechnologies
Employee Count: 2
Keywords: biotechnology research